CCP
RGEN icon

Corient Capital Partners’s Repligen RGEN Stock Holding History

Corient Capital Partners’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,091
Closed -$289K – 762
2021
Q4 		$289K Buy
1,091
+82
+8% +$22.1K 0.02% 532
2021
Q3 		$292K Buy
+1,009
New +$259K 0.02% 502

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Corient Capital Partners's RGEN Position: Q1 2022 in Review

Corient Capital Partners sold out of Repligen (RGEN) in Q1 2022, closing a stake of 1,091 shares — an estimated $289K sold.

Corient Capital Partners first reported a position in RGEN in Q3 2021 and held it in 2 quarters. The position peaked at $292K in Q3 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

  • Corient Capital Partners reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
  • Corient Capital Partners sold 1,091 Repligen shares in Q1 2022, an estimated $289K.
  • Corient Capital Partners first reported a position in Repligen in Q3 2021 and held it in 2 quarters.
  • Corient Capital Partners's Repligen position peaked at $292K in Q3 2021.
  • 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on Corient Capital Partners's 13F filing for Q1 2022, filed 16 May 2022.